Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intravesical Antifibrinolytic for Patients With Hematuria and Clot Retention

NCT04555343 is registered in ClinicalTrials.gov with Fraser Health as lead sponsor.

NCT NCT04555343
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04555343 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intravesical Antifibrinolytic for Patients With Hematuria and Clot Retention
Lead sponsor
Fraser Health
Phase
Phase 1/2
Overall status
Completed
Start date
March 1, 2021
Completion date
October 30, 2021
Enrollment
14 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer, hematuria, nurse physician relations, nurse's role, patient satisfaction, prostate cancer, urinary retention, urologic diseases